Clinical Observation of Relinqing Granule Combined with Ciprofloxacin in Treating Chronic Prostatitis

Phase 4

Recruiting

• Conditions: Chronic prostatitis

• Registration Number: ITMCTR2000003542
• Lead Sponsor: The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

(1) The diagnostic criteria of type II and Type IIIA chronic prostatitis were met;
(2) It is in accordance with the diagnostic criteria of dampness heat stasis and kidney deficiency syndrome;
(3) The age ranged from 18 to 50 years old;
(4) Patients with a course of disease >= 3 months and who had been treated before treatment could be included in the study only after stopping using all relevant Chinese and Western medicines for chronic prostatitis for at least 2 weeks;
(5) Those who voluntarily participate in this clinical trial, and have informed consent and signed informed consent.

Exclusion Criteria

(1) Patients with benign prostatic hyperplasia, prostate tumor, neurogenic bladder dysfunction, urethral malformation or stenosis, severe neurosis;
(2) Patients with urinary tract infection and urethritis;
(3) Other diseases such as ureter, bladder stones, inguinal hernia, pubitis, varicocele, epididymitis, rectocolonitis, lumbosacral myofascitis, etc. should be excluded if local pain is the main manifestation;
(4) Patients with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system;
(5) Psychiatric patients, diabetic patients, urinary calculi patients;
(6) The subjects are participating in clinical trials of other drugs at the same time or using drugs with similar therapeutic effects as the trial drugs;
(7) Allergic constitution (including drug allergy, food allergy and other allergic constitution);
(8) The subjects were not willing to participate in the trial or could not cooperate with the treatment due to alcoholism and / or psychoactive substances, drug abusers and addicts, and avoiding spicy diet;
(9) Those considered unsuitable for clinical trials by the researchers.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
IH-CPSI;Concentration of ciprofloxacin and relinquin markers;

Secondary Outcome Measures

Name	Time	Method
Bacterial culture of prostatic fluid;